Venous Thromboembolism Risk Assessment and Prophylaxis Modalities in Critically Ill Patients-Reference-Cited by-同舟云学术

Venous Thromboembolism Risk Assessment and Prophylaxis Modalities in Critically Ill Patients

Published:2021 Issue:1 Volume:11 Page:134-141
ISSN:2250-1029
Container-title:International Journal Of Pharmaceutical And Phytopharmacological Research
language:
Short-container-title:Int j pharm phytopharm res

Author:

Redzuan Adyani Md,Begum Rubina,Islahudin Farida Hanim,Lau Chee Lan,Mat Wan Rahiza Wan

Publisher

Polaris

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Drug Discovery

Reference32 articles.

1. Alameri MA, Sulaiman SA. Thromboprophylaxis awareness among hospital Pharmacists. Arch. Pharma. Pract. 2019;10(2):31-4.

2. Abdullah IB, Ahmed M, Alhalal DA, AlOtaibi SA, Alanazi M, Alawami IZ, et al. Literature Review on Prophylaxis of Deep Venous Thrombosis and Pulmonary Embolism. Int. J. Pharm. Res. Allied Sci. 2019;8(4):130-5.

3. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001 May 28;161(10):1268-79.

4. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest. 2000 Jan;117(1):178-83.

5. Edmonds MJ, Crichton TJ, Runciman WB, Pradhan M. Evidence-based risk factors for postoperative deep vein thrombosis. ANZ J Surg. 2004 Dec;74(12):1082-97.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug choice to lowering risk contiguity with Morbus Hansen disease: A review article;Journal of Advanced Pharmacy Education and Research;2023